Original Article

You have full text access to this OnlineOpen article

Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features

  1. Julien Champey1,†,
  2. Emmanuelle Corruble1,†,
  3. Jacques-eric Gottenberg1,
  4. Catherine Buhl1,
  5. Tania Meyer1,
  6. Céline Caudmont1,
  7. Elisabeth Bergé1,
  8. Jacques Pellet2,
  9. Patrick Hardy1,
  10. Xavier Mariette1,*

Article first published online: 31 MAY 2006

DOI: 10.1002/art.21990

Issue

Arthritis Care & Research

Arthritis Care & Research

Volume 55, Issue 3, pages 451–457, 15 June 2006

Additional Information

How to Cite

Champey, J., Corruble, E., Gottenberg, J.-e., Buhl, C., Meyer, T., Caudmont, C., Bergé, E., Pellet, J., Hardy, P. and Mariette, X. (2006), Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features. Arthritis & Rheumatism, 55: 451–457. doi: 10.1002/art.21990

Author Information

  1. 1

    Hôpital de Bicêtre, Assistance Publique-Hôpitaux de Paris, Université Paris-11, Le Kremlin Bicêtre, France

  2. 2

    Centre hospitalo-universitaire (CHU), St. Etienne, France

  1. †

    Drs. Champey and Corruble participated equally in this work.

*Service de Rhumatologie, Hôpital de Bicêtre, 78 rue du Général Leclerc, 94275 Le Kremlin Bicêtre, France

Publication History

  1. Issue published online: 31 MAY 2006
  2. Article first published online: 31 MAY 2006
  3. Manuscript Accepted: 18 OCT 2005
  4. Manuscript Received: 30 MAY 2005

Funded by

  • Association Française du Gougerot Sjögren et des syndromes secs

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (86K)

REFERENCES

  • 1
    Price EJ, Venables PJ. Dry eyes and mouth syndrome: a subgroup of patients presenting with sicca symptoms. Rheumatology (Oxford) 2002; 41: 416–22.
  • 2
    Mariette X, Caudmont C, Berge E, Desmoulins F, Pinabel F. Dry eyes and mouth syndrome or sicca, asthenia and polyalgia syndrome? [letter] Rheumatology (Oxford) 2003; 42: 914–5.
  • 3
    Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160–72.
    Direct Link:
  • 4
    Gilboe IM, Kvien TK, Husby G. Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls. J Rheumatol 1999; 26: 1694–700.
  • 5
    Strombeck B, Ekdahl C, Manthorpe R, Wikstrom I, Jacobsson L. Health-related quality of life in primary Sjogren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol 2000; 29: 20–8.
  • 6
    Sutcliffe N, Stoll T, Pyke S, Isenberg DA. Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE), SLE and Sjögren's syndrome (SS), and primary SS. J Rheumatol 1998; 25: 63–8.
  • 7
    Tensing EK, Solovieva SA, Tervahartiala T, Nordstrom DC, Laine M, Niissalo S, et al. Fatigue and health profile in sicca syndrome of Sjögren's and non-Sjögren's syndrome origin. Clin Exp Rheumatol 2001; 19: 313–6.
  • 8
    Tensing EK, Nordstrom DC, Solovieva S, Schauman KO, Sippo-Tujunen I, Helve T, et al. Salivary gland scintigraphy in Sjögren's syndrome and patients with sicca symptoms but without Sjögren's syndrome: the psychological profiles and predictors for salivary gland dysfunction. Ann Rheum Dis 2003; 62: 964–8.
  • 9
    Derogatis L. The SCL-90-R manual-II: administration, scoring and procedures. Baltimore: Clinical Psychometric Research; 1983.
  • 10
    Parker JC, Buckelew SP, Smarr KL, Buescher KL, Beck NC, Frank RG, et al. Psychological screening in rheumatoid arthritis. J Rheumatol 1990; 17: 1016–21.
  • 11
    Sperber AD, Atzmon Y, Neumann L, Weisberg I, Shalit Y, Abu-Shakrah M, et al. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gastroenterol 1999; 94: 3541–6.
    Direct Link:
  • 12
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al, and the European Study Group on Classification Criteria for Sjogren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554–8.
  • 13
    Leplege A, Ecosse E, Verdier A, Perneger TV. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol 1998; 51: 1013–23.
  • 14
    Leplege A, Ecosse E, Pouchot J, Coste J, Perneger T. Le questionnaire MOS SF-36: manuel de l'utilisateur et guide d'interprétation des scores. Paris: ESTEM; 2001.
  • 15
    Perneger TV, Leplege A, Etter JF, Rougemont A. Validation of a French-language version of the MOS 36-Item Short Form Health Survey (SF-36) in young healthy adults. J Clin Epidemiol 1995; 48: 1051–60.
  • 16
    Guelfi JD, Pellet J. La symptom checklist: SCL-90-R: l'évaluation clinique standardisée en psychiatrie. Paris Editions Médicales Pierre Fabre 1996; 1: 77–86.
  • 17
    Pariente P, Guelfi JD. Version francaise de la SCL-90-R: inventaire d'auto-évaluation psychopathologique chez les adultes. Première partie: inventaires multidimensionnelles. Psychiatr Psychobiol 1990; 5: 49–63.
  • 18
    Tatu P, Pellet J, Lang F, Pichon M, Coerchon C. SCL 90 R in a sample of French-speaking subjects free of psychiatric disorders. Ann Med Psychol (Paris) 1994; 152: 187–90. In French.
  • 19
    Thomas E, Hay EM, Hajeer A, Silman AJ. Sjögren's syndrome: a community-based study of prevalence and impact. Br J Rheumatol 1998; 37: 1069–76.
  • 20
    Bowman SJ, Booth DA, Platts RG, and the UK Sjögren's Interest Group. Measurement of fatigue and discomfort in primary Sjögren's syndrome using a new questionnaire tool. Rheumatology (Oxford) 2004; 43: 758–64.
  • 21
    Drosos AA, Angelopoulos NV, Liakos A, Moutsopoulos HM. Personality structure disturbances and psychiatric manifestations in primary Sjögren's syndrome. J Autoimmun 1989; 2: 489–93.
  • 22
    Strombeck B, Ekdahl C, Manthorpe R, Jacobsson LT. Physical capacity in women with primary Sjögren's syndrome: a controlled study. Arthritis Rheum 2003; 49: 681–8.
    Direct Link:
  • 23
    Valtysdottir ST, Gudbjornsson B, Hallgren R, Hetta J. Psychological well-being in patients with primary Sjögren's syndrome. Clin Exp Rheumatol 2000; 18: 597–600.
  • 24
    Le Pape A, Lecompte T. Prévalence et prise en charge médicale de la dépression: France 1996–1997. Paris: Centre de recherche d'étude et de documentation en économie de la santé (Credes); 1999. p. 108.
  • 25
    Lovell A. Etude sur la surveillance dans le champ de la santé mentale. Rapport final. InVS, Octobre 2004, p.25. URL: http://www.invs.sante.fr/publications/2005/sante_mentale_110105/etude_santementale.pdf.
  • 26
    Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137–45.
    Direct Link:
  • 27
    Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 2286–91.
  • 28
    Bowman SJ, Booth DA, Platts RG, Field A, Rostron J, and the UK Sjogren's Interest Group. Validation of the Sicca Symptoms Inventory for clinical studies of Sjögren's syndrome. J Rheumatol 2003; 30: 1259–66.
View Full Article (HTML) Get PDF (86K)